29.09.2011 • News

Lonza Obtains French Antitrust Clearance For Arch Chemicals Offer

Lonza Group, a supplier to the life science industries, said it has obtained antitrust clearance from the Autorité de la Concurrence in France for its tender offer for 100% of the outstanding shares of common stock of Arch Chemicals.

The tender offer is at a price of $47.20 per share in cash and remains subject to antitrust clearance in the U.S. The tender offer had previously been extended to September 30. It may be further extended if its conditions remain unsatisfied.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read